The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Goode, expressed enthusiasm about the results, indicating that this technology brings continuous glucose monitoring ... with diabetes. Glucotrack’s CBGM is a long-term, implantable system ...

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable CGM systems for people with diabetes, announced it has filed for CE Mark ...

RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq ... marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous ...

RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack ... marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous blood ...